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Complete genomes of HPV101 and HPV103 were PCR amplified and cloned from cervicovaginal cells of a 34-year-old female with cervical
intraepithelial neoplasia grade 3 (CIN 3) and a 30-year-old female with a normal Pap test, respectively. HPV101 and HPV103 contain 4 early
genes (E7, E1, E2, and E4) and 2 late genes (L2 and L1), but both lack the canonical E6 ORF. Pairwise alignment similarity of the L1 ORF
nucleotide sequences of HPV101 and HPV103 indicated that they are at least 30% dissimilar to each other and all known PVs. However,
similarities of the other ORFs (E7, E1, E2, and L2) indicated that HPV101 and HPV103 are most related to each other. Phylogenetic analyses
revealed that these two types form a monophyletic clade, clustering together with the gamma- and pi-PV groups. These data demonstrated that
HPV genomes closely related to papillomaviruses identified from cutaneous epithelia can be isolated from the genital mucosal region. Moreover,
this is the first report of HPVs lacking an E6 ORF and phylogenetic evidence suggests this occurred subsequent to their emergence from the
gamma-/pi-PVs.
© 2006 Elsevier Inc. All rights reserved.Keywords: Human papillomavirus; Novel type; Complete genome; Phylogeny; Molecular clockIntroduction
Papillomaviruses (PVs) are a heterogeneous group of DNA
viruses with circular double-stranded DNA genomes about
8 kb in size that contain three general regions. An upstream
regulatory region (URR) contains sequences that control
transcription and replication, an early region contains genes
(e.g., E6, E7, E1, E2, E4, and E5) involved primarily in
enzymatic activities, and a structural region consisting of the
L1 capsid protein and L2 that facilitates packaging of viral
DNA. PVs are highly species-specific pathogens that cause⁎ Corresponding author. Fax: +1 718 430 8975.
E-mail address: burk@aecom.yu.edu (R.D. Burk).
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doi:10.1016/j.virol.2006.10.022proliferation of predominantly epithelial cells in a wide range
of host species. Currently, over 100 types of human papillo-
maviruses (HPVs) and at least 28 types of nonhuman PVs have
been fully characterized. For a papillomavirus to be recognized
as a distinct type, the DNA sequence of the L1 open reading
frame (ORF) of the cloned genome should be no more than
90% similar to previously typed PVs (de Villiers, 2001; Delius
et al., 1998). Historically, PV phylogenies based on tissue
tropism and genomic sequence have typically been subdivided
into clades associated with mucosal/genital lesions, cutaneous
lesion/epidermodysplasia verruciformis (EV) disease, and three
animal groups: the artiodactyl ruminants, avians, and a group
containing canine, feline, rabbit, and rodent (Chan et al., 1995;
de Villiers, 2001; de Villiers et al., 2004). Based on the L1
ORF, papillomaviruses have recently been classified into
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genera; however, analyses based on the early region of HPV
genomes indicate that the phylogeny of the alpha-PVs is more
complex than initially suspected (Narechania et al., 2005).
Most PVs target the basal cells of dermal or mucosal
epithelia, and infection has been implicated in both benign and
malignant lesions of epithelia in a broad range of animals and
humans. Some papillomatous proliferations induced by specific
types of PVs have a high risk for malignant progression
(Clifford et al., 2003; Munoz et al., 2003). Nevertheless, the
majority of PVs appear to be nonpathogenic, since a wide
variety of different types can be detected at different sites of
healthy skin of human and animals (Antonsson et al., 2003;
Antonsson and Hansson, 2002), and over 40 types have been
detected in the mucosal epithelia of humans with only a
minority associated with high-risk disease (Munoz et al., 2003).
PVs seem to have coexisted with their host over long periods of
time. With the exception of certain bovine PVs (BPVs), each
PV type has been found only in a single host species. In some
host species, particularly in human beings, numerous PV types
have been found. The available data suggest associations
between PV types, pathological properties, and tissue tropism;
however, it is unclear what molecular properties link specific
PV types to particular hosts and tissues, and, in particular, how
numerous types that have similar tissues tropisms (e.g., mucosal
or cutaneous) and pathologic manifestation evolved in the same
host.
This report describes the characterization of two novel HPV
types, HPV101 and HPV103, isolated from the cervicovaginal
cells using an overlapping PCR method. The viruses were
initially identified by PCR amplification of a 480-bp fragment
using FAP primers (Forslund et al., 1999). Nucleotide sequence
similarity by pairwise alignment of 5 ORFs (E7, E1, E2, L2, and
L1) indicated that they are closely related to the gamma-PV
genus (usually associated with cutaneous lesions) and not alpha-
PVs. Furthermore, both HPV genomes lack an E6 ORF.
Phylogenetic analyses revealed that HPV101 and HPV103 form
a monophyletic group at the root of the gamma- and pi-PV
genera.Table 1
Nucleotide sequence pairwise similarity (%) of HPV101 and HPV103 ORFs with r
HPV101
HPV103
Pi-PV Gamma-PV
HPV103 HaOPV HPV65 HPV60 HPV
E7 69.7 42.1 57.0 56.4 58.8
– 43.1 57.5 51.3 55
E1 73.3 60.2 62.4 62.4 58.8
– 60.9 62.9 63.6 61
E2 68.8 58.6 58.5 61.5 58.6
– 59.5 59.7 61.4 59
L2 67.1 56.4 57.7 58.0 56.3
– 55.5 58.8 57.3 57
L1 64.7 59.4 60.9 58.1 58.8
– 65.2 65.3 61.6 64Results and discussion
Determination of the complete genome sequences
The complete nucleotide sequences of HPV101 and HPV103
contain 7259 bp and 7263 bp, with a GC-content of 42.8% and
41.6%, respectively. The complete nucleotide sequences of
HPV101 and HPV103 L1 ORFs share 60.9% and 65.3%
similarity to HPV65 L1 (gamma-PV); 62.6% and 59.5% to
HPV19 L1 (beta-PV); 59.4% and 65.2% to HaOPV (pi-PV);
and 64.7% similarity to each other (Table 1). HPV101 and
HPV103 are at least 30% dissimilar to all known PVs and
satisfy the criteria for novel types.
The genomes of HPV101 and HPV103 contain six ORFs,
potentially encoding four early genes (E7, E1, E2, and E4) and
two late genes (L2 and L1) (Supplement 1).
The putative E7 ORFs of HPV101 and HPV103 contain
one conserved zinc binding domain, CxxC(x)29CxxC, and a
motif (LxCxE) for binding to the pRB protein. The ATP-
binding site of the ATP-dependent helicase (GPPDTGKS for
HPV101, GPSDTGKS for HPV103) is conserved in the
carboxy-terminal region of E1. The E4 ORF contains a start
codon and overlaps the E2 ORF. A polyadenylation consensus
sequence (AATAAA) for processing of early viral mRNA
transcripts is present at the beginning of the L2 gene
(nucleotide [nt] 3524 to 3529 for HPV101, nt 3453 to 3458
for HPV103). The major (L1) and minor (L2) capsid proteins
of both types show a nuclear localization signal at their 3′
end.
Both HPV101 and HPV103 lack a canonical E6 ORF.
Although there is a novel ORF downstream of the L1 ORF in
HPV101 (nt 6734 to 7225, 6995 for the first ATG) calculated
to produce an 8.9 kDa protein (Supplement 1), it does not
contain a zinc binding domain and is embedded in the long
control region (LCR). This is the first characterization of
human PVs lacking an E6 ORF. Interestingly, bovine pa-
pillomavirus type 3 (BPV3), BPV4 and BPV6, bird PVs
Fringilla coelebs papillomavirus (FPV), and Psittacus eritha-
cus timneh papillomavirus (PePV) also lack a definable E6epresentative PVs
Beta-PV Mu-PV Alpha-PV Eta-PV
48 HPV4 HPV19 HPV1 HPV16 FPV
57.4 55.9 52.9 54.5 33.1
.1 60.6 56.1 53.0 54.3 34.1
63.3 60.5 60.9 61.1 54.9
.7 63.8 61.4 61.5 60.0 54.0
59.0 51.4 57.7 56.8 53.2
.4 60.3 50.8 57.3 57.5 52.4
58.2 56.5 55.6 53.4 51.3
.0 59.1 57.6 56.2 55.9 51.9
62.0 62.6 58.3 61.2 54.2
.2 64.8 59.5 60.8 59.9 57.1
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spinipinnis papillomavirus (PsPV) that causes genital warts in
small cetaceans, has an E6 ORF but lacks an identifiable E7. It
appears that E6 and E7 functions are either not required by
these viruses or are performed by another viral (or host)
protein. One hypothesis is that ancient genomic rearrangement
may have contributed to the evolution of PV types lacking E6
or E7 ORFs. The E6 and E7 proteins, the major oncogenes in
PVs, may play a central function in adapting PV genomes to
various hosts and tissues. In contrast, the E1, E2, L2, and L1
ORFs, are well conserved in all PVs and their products are
essential proteins for the PV life cycle (Terai et al., 2002). In
addition, HPV101 and HPV103 lack a distinct E5 ORF. The
region between the early and late genes (ELR) is about 100 bp
in length.
The sequence between the stop codon of L1 and the first
ATG of E6 is known as the long control region (LCR) or the
upstream regulatory region (URR), a noncoding region (NCR)
containing many of the cis-acting regulatory sequences that
control viral transcription and replication. Because of the lack of
a definable E6 ORF for HPV101 and HPV103, the LCR
sequence was defined as the region between the L1 stop codon
and the first start codon of the E7 ORF. The LCR is 678 bp in
HPV101 (nt 6582 to 7259) and 771 bp in HPV103 (nt 6493 to
7263) (Supplement 2). Analysis of the HPV101 LCR revealed
three typical palindromic E2-binding sites [ACC(N)6GGT] at nt
6806 to 6817, 6922 to 6933, 6999 to 7010, and one modified
putative E2-binding site [AAC(N)6GGT] at nt 6893 to 6904.
The LCR also contains a second overlapping polyadenylation
site (AATAAA; nt 6642 to 6647 vs. 6646 to 6651) at the 5′ end.
Multiple binding sites for transcriptional regulatory factors such
as AP-1 (Chan et al., 1990), NF-1 (Apt et al., 1993), SP-1 (Gloss
and Bernard, 1990), transcriptional enhancer factors (TEF)-1
(Ishiji et al., 1992), and YY-1 (Dong et al., 1994) are also
present within the LCR region. Analysis of HPV103 LCR
revealed two typical palindromic E2-binding sites (nt 6775 to
6786 and 6968 to 6979), and similar to HPV101, it also contains
a polyadenylation site (nt 6753 to 6758) and multiple
transcription factor binding sites.
DNA diversity and phylogenetic analyses of HPV101 and
HPV103
The nucleotide sequence similarity of HPV101 and HPV103
to HPV1, HPV4, HPV48, HPV60 and HPV65 (gamma-PVs),
HPV19 (a beta-PV), HPV16 (a high-risk alpha-PV), and
chaffinch (Fringilla coelebs) PV (FPV) was investigated by
pairwise alignment of each ORF (Table 1). The selected types
represent the main PV clades. The nucleotide sequence
similarity of HPV101 and HPV103 L1 ORFs was 64.7%
when compared to each other; whereas they were approximately
60–65% similar to the L1 of PVs in other genera. However, all
other ORFs similarities (E7, E1, E2, and L2) indicated that these
two novel types are most closely related to each other.
Furthermore, HPV101 and HPV103 are more closely related
to the gamma-PVs (e.g., HPV4, HPV65) than to the alpha-PVs
(e.g., HPV16).In order to examine the phylogenetic relationship among
HPVs and other animal PVs, trees using multiple algorithms
were constructed. The Bayesian tree (Fig. 1) inferred from the
concatenated amino acids and nucleotide sequences of six ORFs
(E1, E2, E6, E7, L1, and L2) clusters all characterized PVs into
genera consistent with one phylogeny, similar but not identical
to that proposed by de Villiers et al. (2004). The incongruence of
the branching order of some major genera between these two
trees could be the result of an early recombination event, an
ecological niche change, and/or asymmetric genome conver-
gence driven by intense selection across different PV genes
(Narechania et al., 2005). As shown in the Fig. 1, large
evolutionary distances significantly separate PVs of hosts
belonging to different mammalian orders (e.g., human and
bovine). There is also a significant distance between mamma-
lian PVs and avian PVs (FPVand PePV) that infect birds and not
mammals. This distribution supports the notion of an ancient
virus–host association implicit in a coevolution history.
Except for HPV1, 41, and 63, all characterized HPVs are
subdivided into three genera: one is predominantly associated
with genital mucosal infection (alpha-PVs) and two predomi-
nantly infect cutaneous epithelia (beta- and gamma-PVs). Mole-
cular phylogeny is consistent with the classification by tissue
tropism. This suggests that selection pressure, e.g., species-
specific immunoresponses from the host, may have shaped the
evolution of PVs. HPV101 and HPV103 diverged near the root
of the gamma-PV genus, and are joined in a monophyletic group
by the pi-PV (represented by hamster oral PV, HaOPV). The L1
ORF of HPV103 has a higher similarity to the L1 nucleotide
sequence of HaOPV (Table 1); however, it is difficult to localize
HPV101 and HPV103 in a phylogenetic tree by placing them
into the gamma-PV genus or the pi-PV genus, as they potentially
form a novel genus inferred from the nucleotide sequence
similarities. HPV101 and HPV103 seem to have common
features with HaOPVand are close to papillomaviruses involved
in cutaneous neoplasia; whereas, the lack of an E6 ORF and the
mucosal tissue tropismmay separate them from the pi-PV group.
Separate Bayesian trees for early genes (E1 and E2) and late
genes (L1 and L2) were compared to determine whether there is
incongruence of the phylogenetic signals emanating from
different genes, which would potentially reflect different
evolutionary histories or different evolutionary pressures
(Narechania et al., 2005). Representative types of the beta-
and gamma-PV genera were utilized for tree construction. As
shown in Fig. 2, the phylogeny indicated stable and consistent
patterns by the early and late gene regions, which was
confirmed by the congruence test of ILD in PAUP (data not
shown). Therefore, HPV101 and HPV103 genomes have
evolved as a unit rather than certain genes having different
evolutionary histories. HaOPV, however, showed variable
phylogenetic positions between early and late genes.
Molecular clock prediction
The divergence times of the most recent common ancestor
(MRCA) of representative PVs were predicted and are shown in
Fig. 3. The MRCA of HPV was predicted to occur around 30–
Fig. 1. Bayesian tree of 125 papillomavirus types inferred from the concatenated amino acids and nucleotide sequences of six ORFs (E6, E7, E1, E2, L2, and L1). The
ORF sequence was left blank if unavailable. Classification at the “genus” level is according to de Villiers (10). The number at the ends of each of the branches identifies
an HPV type. All other abbreviations refer to animal PVs but the RTRX7. Two novel HPV types in this work (HPV101 and HPV103) form a monophyletic clade at the
root of the gamma-PV genus. PV genomes representing main clades of papillomaviruses that were used in Table 1 are were highlighted in gray. All complete genome
sequences of PVs were obtained from NCBI/GenBank database (with their accession numbers): HPV01a (NC_001356), HPV02a (NC_001352), HPV03
(NC_001588), HPV04 (NC_001457), HPV05 (NC_001531), HPV06 (NC_000904), HPV07 (NC_001595), HPV08 (NC_001532), HPV09 (NC_001596), HPV10
(NC_001576), HPV11 (NC_001525), HPV12 (NC_001577), HPV13 (NC_001349), HPV14D (NC_001578), HPV15 (NC_001579), HPV16R (AY686581), HPV17
(NC_001580), HPV18R (AY262282), HPV19 (NC_001581), HPV20 (NC_001679), HPV21 (NC_001680), HPV22 (NC_001681), HPV23 (NC_001682), HPV24
(NC_001683), HPV25 (NC_001582), HPV26 (NC_001583), HPV27 (NC_001584), HPV28 (NC_001684), HPV29 (NC_001685), HPV30 (NC_001585), HPV31
(NC_001527), HPV32 (NC_001586), HPV33 (NC_001528), HPV34 (NC_001587), HPV35 (NC_001529), HPV36 (NC_001686), HPV37 (NC_001687), HPV38
(NC_001688), HPV39 (NC_001535), HPV40 (NC_001589), HPV41 (NC_001354), HPV42 (NC_001534), HPV43 (NC_005349), HPV44 (NC_001689), HPV45
(NC_001590), HPV47 (NC_001530), HPV48 (NC_001690), HPV49 (NC_001591), HPV50 (NC_001691), HPV51 (NC_001533), HPV52 (NC_001592), HPV53
(NC_001593), HPV54 (NC_001676), HPV55 (NC_001692), HPV56 (NC_001594), HPV57 (NC_001353), HPV58 (NC_001443), HPV59 (NC_001635), HPV60
(NC_001693), HPV61 (NC_001694), HPV62 (NC_006357), HPV63 (NC_001458), HPV65 (NC_001459), HPV66 (NC_001695), HPV67 (NC_004710), HPV68
(DQ080079), HPV69 (NC_002171), HPV70 (NC_001711), HPV71 (NC_002644), HPV72 (NC_006164), HPV73 (NC_006165), HPV74 (NC_004501), HPV75
(NC_006166), HPV76 (NC_006167), HPV77 (NC_006168), HPV78 (unpublished), HPV80 (NC_006169), HPV81 (NC_005351), HPV82 (NC_002172), HPV83
(NC_000856), HPV84 (NC_002676), HPV85 (NC_004762), HPV86 (NC_003115), HPV87 (NC_002627), HPV89 (NC_004103), HPV90 (NC_004104), HPV91
(NC_004085), HPV92 (NC_004500), HPV93 (NC_005133), HPV94 (NC_005352), HPV95 (AJ620210), HPV96 (NC_005134), HPV101 (DQ080081), HPV103
(DQ080078), bovine BPV1 (X02346), BPV2 (NC_001521), BPV3 (NC_004197), BPV4 (NC_004711), BPV5 (NC_004195), BPV6 (NC_005350), canine oral CoPV
(NC_001619), common chimpanzee ChPV (NC_001838), cottontail rabbit CRPV (NC_001541), deer DPV (NC_001523), Erethizon dorsatumEdPV-1 (AY684126),
Equinus caballus EquiPV (NC_004194), European elk EEPV (NC_001524), feline FdPV (NC_004765), Fringilla coelebs FPV (NC_004068), Hamster oral HaOPV
(E15111), multimammate rat MnPV (NC_001605), ovine OvPV1 (NC_001789), ovine OvPV2 (NC_001790), Procyon lotor PIPV-1 (AY763115), Phocoena
spinipinnis PsPV (NC_003348), Psittacus erithacus PePV (NC_003973), pygmy chimpanzee PcPV (NC_006163), Trichechus manatus latirostris TmPV1
(NC_006563), rabbit oral ROPV (NC_002232), reindeer RPV (NC_004196), and rhesus monkey RhPV (NC_001678).
450 Z. Chen et al. / Virology 360 (2007) 447–45350 million years ago (Mya), and subsequently split into three
potential ancestors of HPV1 (also including HPV41 and
HPV63), genital HPVs (e.g., HPV16), and cutaneous HPVs(e.g., HPV19 and HPV4). The MRCA of present-day Gamma
HPVs was predicted to have occurred approximately
15–30 Mya.
Fig. 2. Bayesian trees inferred from the concatenated amino acids and nucleotide sequences of early (E6, E7, E1, and E2) and late (L2 and L1) ORFs. The ORF
sequence was left blank if unavailable. Numbers on or near branches indicate support indices from multiple algorithms in the following order: Bayesian credibility
value using MrBayes; maximum parsimony (MP) bootstrap percentage and neighbor joining (NJ) bootstrap percentage using PAUP. An asterisk (*) indicates complete
agreement between methods. “n” reflects disagreement between a method and the reference Bayesian tree at a given node. HPV101 and HPV103 genomes are
highlighted in gray.
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suggests that these viruses already existed at the time humans
originated as a species, a few hundred thousand years ago (Ho et
al., 1993; Ong et al., 1993). Since between 10 and 20 million
years ago a variety of hominoid primates lived in Africa, Europe
and Asia (Andrews, 1992), the genomic heterogeneity and
organization typical of HPVs must have existed prior to that
time. Our MRCA prediction confirmed that all HPV types
should have existed before the origin of humans. HPV101 and
HPV103, however, are the only two HPVs that lack an E6 gene.
A gene loss in this lineage seems to be the most parsimoniousFig. 3. Molecular tree topology of representative papillomaviruses combined
with dating of the phylogenetic nodes. Branch lengths are proportional to
divergence times. Numbers above the nodes are the mean estimated divergence
time (in million years, Mya). The bars in gray represent the 95% highest
posterior density (HPD) interval for the divergence times. A Bayesian Markov
chain Monte Carlo (MCMC) method was used to calculate divergence times in
the BEAST program by selecting the uncorrelated lognormal distribution
(UCLD) model. The node of the most recent common ancestor (MRCA)
between the clade of HPV101/103 and the Gamma HPVs is denoted with a black
circle.explanation, rather than a number of independent acquisitions
of E6 assuming that the common ancestor of HPVs did not have
an E6 gene. Hence, the loss of E6 might have happened during
the development of the evolutionary lineage from the MRCA of
the gamma- and pi-PVs to the emergence of HPV101 and
HPV103 (≈15–30 Mya). However, genomic rearrangement or
lack of selective pressure may be responsible for PV types
lacking an E6 ORF.
In this work, we report the characterization of two novel
HPVs obtained from cervicovaginal cells. Based on the
genomic and phylogenetic analyses, these two novel types are
related to gamma-PVs although they were isolated from
cervicovaginal cells, since (i) the region between the early
and late genes (ELR) is about 100 bp in length and lacks a
distinct E5 ORF, similar to beta- and gamma-PVs (de Villiers et
al., 2004); (ii) HPV101 and HPV103 are more closely related to
the gamma-PV genus (e.g., HPV65) than to the alpha-PV genus
(e.g., HPV16) inferred from sequence comparisons of 5 ORFs;
and (iii) they phylogenetically form a clade clustering together
with the gamma- and pi-PV genera.
Materials and methods
Specimens and HPV cloning
HPV101 was isolated from the cervicovaginal (CV) cells
from a 34-year-old female with cervical intraepithelial neoplasia
grade 3 (CIN 3) that also contained HPV33 and HPV35.
HPV103 was isolated from the CV cells of a 30-year-old female
with a normal cytological screening test. Both females were
participants of a population-based HPV study in Costa Rica
(Herrero et al., 2000). HPV DNA was initially identified by
PCR amplification. The 480 bp fragments amplified by the FAP
primers within the L1 ORF were sequenced (Forslund et al.,
1999). A BLAST search against GenBank revealed that
sequences of both fragments were less than 70% related to
452 Z. Chen et al. / Virology 360 (2007) 447–453other PV genomes. Hence, type-specific primer sets were
thereafter designed based on the sequence of the FAP product
and a consensus region of E1 ORF to allow amplification of the
complete genome in two fragments (3249 bp and 4105 bp for
HPV101, 3253 bp and 4161 bp for HPV103). Oligonucleotide
primer sequences used in this study are available from the
authors.
For overlapping PCR, an equal mixture of the AmpliTaq
Gold Taq DNA polymerase (Applied Biosystems, USA) and
Pwo Platinum Taq DNA Polymerase (High Fidelity, Invitrogen,
USA) were utilized as previously described (Terai and Burk,
2001a,b). PCR products were separated by electrophoresis in
agarose gels, stained with ethidium bromide, and visualized
under ultraviolet illumination.
After confirmation of appropriate product size, each PCR
product was purified (Qiagen Gel Extraction Kit, Qiagen,
Valencia, CA), ligated into the pGEM-T easy vector (Promega,
Madison, WI), and sequenced by the Einstein Sequencing
Facility. Subsequent sequencing was performed using primer
walking. The complete genomic sequences were determined
from a combination of sequences from the two overlapping
amplification products. DNA clones were submitted to the
Human Papillomavirus Reference Laboratory (Heidelberg,
Germany) for official designation. The genome sequences of
HPV101 and HPV103 were submitted to NCBI/GenBank
database (Access numbers: HPV101, DQ080081; HPV103,
DQ080078).
Phylogenetic analysis and tree construction
Phylogenetic trees were inferred from alignments of
concatenated amino acids and nucleotide sequences of six
ORFs (E6, E7, E1, E2, L2, and L1) of papillomaviruses. The
amino acid sequence of each ORF was aligned using ClustalX
software (Thompson et al., 1997). Codon Align (ver 1.0)
(available from Web site http://www.sinauer.com/hall/) was
implemented to align the nucleotide sequence of each coding
region corresponding to the aligned proteins.
The computer program MrBayes v3.0b4 (Huelsenbeck and
Ronquist, 2001) was used for Bayesian tree construction, with
100,000 cycles for the Markov chain Monte Carlo (MCMC)
algorithm. The gamma model was set for among-site rate
variation, and allowed all substitution rates of aligned sequences
to be different. Maximum parsimony (MP) and neighbor joining
(NJ) trees were calculated by a heuristic search in PAUP*
v4.0b10 (Swofford, 1998). For maximum parsimony analyses,
amino acid and nucleotide sequences were reduced to
phylogenetically informative sites. Data were bootstrap
resampled 1000 times. Sequences of related PVs analyzed in
this work are available from NCBI database.
A computational algorithm to test the incongruence length
difference (ILD) was used to assess the relative degrees of
incongruence across different node/partition pairs (Narechania
et al., 2005). The partition homogeneity test employed in the
PAUP* v4.0b10 (Swofford, 1998) was performed by treating
early and late genes as separate partitions. The ILD values were
calculated.Molecular divergence estimates
In order to predict the potential divergence times of papil-
lomaviruses, a Bayesian Markov chain Monte Carlo (MCMC)
method was used in the BEAST 1.3 program (Drummond and
Rambaut, 2003). The complete L1 nucleotide sequences of
representative types were selected for prediction. Gblocks
(Castresana, 2000) was used to refine ambiguous alignment.
We assumed a general time-reversible model of nucleotide
substitution with gamma-distributed rate heterogeneity among
sites and a proportion of invariant sites. In addition, we assumed
an uncorrected lognormal distribution (UCLN) molecular clock
model of rate variation among branches in the tree. A mean
substitution rate was set to 1.84×10−08 (Lower, 1.27×10−08;
Upper, 2.35×10−08) substitutions per site per year. The MCMC
analysis was run for 10,000,000 steps. Results were determined
by Tracer 1.2 (Rambaut and Drummond, 2003).
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